PharmaTimes -
October 2015


News Review
CDF shake-up / GPs and pharma’s growing divide / Dead end for off-patent drugs bill / Pharma’s transparency drive


Education, education, education
Pharma has a crucial role in providing medical education, but must be fully transparent

Rise of the machines
Artificial intelligence is the key to smarter procurement and cost savings

Medical devices under the microscope
Medical devices could soon come under increased scrutiny as the EU’s new regulation proposals enter final discussions

Power trip 
Pharma companies in a dominant market position need to be sure they are not abusing their position or risk the consequences

Battle of the Pacific
What the Trans-Pacific trade deal means for pharma

Recent trends in pharma M&A / Pfizer in talks to acquire Allergan / AstraZeneca snaps up ZS Pharma / Shire buys potential competitor Dyax


Taking a breath
Pharma’s role in tackling the challenges of Chronic Obstructive Pulmonary Disease

Voyage of rediscovery
Repurposing drugs can be a quick, inexpensive solution to diseases, but pharma has to be careful when repricing older medicines


Uniphar’s Padraic Dempsey on the healthcare industry in the UK and Ireland

This month’s job moves and new appointments

49 PatientFiles

COPD patient Joan McCarthy says that pharma could do more to educate COPD patients

Business Insight

It only takes one applicant to fill a job

Download our apps

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.

Go to the App Store or Google Play and search for 'PharmaTimes' to download our free app.